Literature DB >> 3183669

Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia.

S I Harik1, S A Gravina, R N Kalaria.   

Abstract

The effect of chronic hyperglycemia on the glucose transporter moiety of the blood-brain barrier and cerebral cortex was studied in rats 3 weeks after the administration of a single intravenous dose of streptozotocin (60 mg/kg), using specific [3H]cytochalasin B binding methods. Streptozotocin-treated rats developed hyperglycemia, as well as polydipsia and polyuria, and failed to gain weight. The density of D-glucose-displaceable cytochalasin B binding sites in the brain microvessels of streptozotocin-treated hyperglycemic rats was increased by about 30% compared with those of control rats, without change in the affinity of binding. Chronic hyperglycemia had no effect on the density or affinity of specific binding of cytochalasin B to cerebral cortical membranes. These findings do not support the hypothesis that glucose transporters in brain microvessels comprising the blood-brain barrier are "down-regulated" in chronic hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183669     DOI: 10.1111/j.1471-4159.1988.tb01180.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain.

Authors:  S F Leong; T K Leung
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

2.  Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS.

Authors:  Fei Du; Yi Zhang; Xiao-Hong Zhu; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.